Benserazide Hydrochloride

ATC — · 3 markets · 22 records

Benserazide Hydrochloride 3 markets · 22 records Forms
Filters
MarketAU 8FR 8CA 6
Kind

AU 8 records · 5 shown of 6 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

  • 28.5 mgcapsule CombinationBenserazide Hydrochloride 28.5 mg + Levodopa 100 mgMADOPAR 125 levodopa 100 mg and benserazide 25 mg capsule bottleMADOPAR HBS 125 levodopa 100 mg and benserazide 25 mg capsule bottle also in FR unknown
  • 28.5 mgtablet CombinationBenserazide Hydrochloride 28.5 mg + Levodopa 100 mgMADOPAR 125 levodopa 100 mg and benserazide 25 mg capsule bottleMADOPAR RAPID 125 levodopa 100 mg and benserazide 25 mg dispersible tablet bottle unknown
  • 57 mgcapsule CombinationBenserazide Hydrochloride 57 mg + Levodopa 200 mgMADOPAR 250 levodopa 200 mg and benserazide 50 mg capsule bottle also in FR unknown
  • 14.25 mgcapsule CombinationBenserazide Hydrochloride 14.25 mg + Levodopa 50 mgMADOPAR 62.5 levodopa 50 mg and benserazide 12.5 mg capsule bottle also in FR unknown
  • 57 mgtablet CombinationBenserazide Hydrochloride 57 mg + Levodopa 200 mgMADOPAR 250 levodopa 200 mg and benserazide 50 mg capsule bottle unknown
Other strengths: 1 · 1 dosage forms Otras concentraciones: 1 · 1 formas farmacéuticas 其余规格 1 个 · 涉及 1 种剂型 其餘規格 1 個 · 涉及 1 種劑型
tablet · 114.25 mg

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 8 records · 5 shown of 5 Source Base de données publique des médic · Data as of 2026-11-03 · some records have no stated strength

Combination products containing this ingredient

  • 28.5 mgcapsule CombinationBenserazide Hydrochloride 28.5 mg + Levodopa 100 mgMODOPAR 125 (100 mg/25 mg), gélule also in AU
  • 57 mgcapsule CombinationBenserazide Hydrochloride 57 mg + Levodopa 200 mgMODOPAR 250 (200 mg/50 mg), gélule also in AU
  • 14.25 mgcapsule CombinationBenserazide Hydrochloride 14.25 mg + Levodopa 50 mgMODOPAR 62,5 (50 mg/12,5 mg), gélule also in AU
  • 28.48 mgtablet CombinationBenserazide Hydrochloride 28.48 mg + Levodopa 100 mgMODOPAR 125 DISPERSIBLE (100 mg/25 mg), comprimé sécable pour suspension buvable
  • 28.5 mgcapsule · extended-release CombinationBenserazide Hydrochloride 28.5 mg + Levodopa 100 mgMODOPAR L.P. 125 (100 mg/25 mg), gélule à libération prolongée
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名LEVODOPA/BENSERAZIDE TEVA 100 mg/25 mg, gélule ×9

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 6 records · 3 shown of 3 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Combination products containing this ingredient

  • 50 mgcapsule CombinationBenserazide Hydrochloride 50 mg + Levodopa 200 mgMINT-LEVODOPA/BENSERAZIDEPROLOPA 200-50
  • 25 mgcapsule CombinationBenserazide Hydrochloride 25 mg + Levodopa 100 mgMINT-LEVODOPA/BENSERAZIDEPROLOPA 100-25
  • 12.5 mgcapsule CombinationBenserazide Hydrochloride 12.5 mg + Levodopa 50 mgMINT-LEVODOPA/BENSERAZIDEPROLOPA 50-12.5
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.